<code id='7BE8A70438'></code><style id='7BE8A70438'></style>
    • <acronym id='7BE8A70438'></acronym>
      <center id='7BE8A70438'><center id='7BE8A70438'><tfoot id='7BE8A70438'></tfoot></center><abbr id='7BE8A70438'><dir id='7BE8A70438'><tfoot id='7BE8A70438'></tfoot><noframes id='7BE8A70438'>

    • <optgroup id='7BE8A70438'><strike id='7BE8A70438'><sup id='7BE8A70438'></sup></strike><code id='7BE8A70438'></code></optgroup>
        1. <b id='7BE8A70438'><label id='7BE8A70438'><select id='7BE8A70438'><dt id='7BE8A70438'><span id='7BE8A70438'></span></dt></select></label></b><u id='7BE8A70438'></u>
          <i id='7BE8A70438'><strike id='7BE8A70438'><tt id='7BE8A70438'><pre id='7BE8A70438'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:52

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
          Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          Microsoft's Peter Lee: Generative AI could help doctors be more human

          AlexHogan/STATGenerativeAIishavingamoment.PeterLee,whooverseesMicrosoft’sapproachtohealthcareandco-a